GLP-1 analogs (Enteris Biopharma)

N/A

Report date: 2025/03/20 14:48:29

Base Information

Drug NameGLP-1 analogs (Enteris Biopharma)
Drug Alias NameGLP-1 analogs (Unigene)glucagon-like-peptide-1 analogs (Unigene)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsInsulin release stimulants
TargetsGlucagon-like peptide 1 receptorInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUnigene Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnteris Biopharma Inc
Inactive CompaniesUnigene Laboratories Inc
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A